| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
March 14, 2005 |
|
|
| |
|
|
| |
|
|
|
IBC Life Sciences, Hilton Boston Logan Airport, Boston, MA
June 6-8, 2005
Through improving the preclinical assessment of drug efficacy, researchers can make product improvements to increase the probability of market success, help streamline clinical trials and identify characteristics of candidates that may result in late stage attrition. As pharmaceutical science evolves, so too does the quality of predictive methods and technologies used for early efficacy assessment. By attending this meeting, you will learn about the state of the art in early efficacy assessment from leading industry and academic researchers and return to your lab with new approaches you can apply immediately to improve your research processes. To register or view full details, visit www.IBCLifeSciences.com/3143, or call +1 508-616-5550 x1004.
|
|
|
|
|
|
|
|
Organized by:
|
|
IBC Life Sciences |
|
|
Invited Speakers:
|
|
-
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
-
|
|
|
|
|
|
|
|
Registration:
|
|
Phone: 508-616-5550 x1004
Fax: 508-616-5522
Email: reg@ibcusa.com
|
|
|
E-mail:
|
|
reg@ibcusa.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|